Prime Medicine, Inc. (PRME)
(Delayed Data from NSDQ)
$3.51 USD
+0.10 (2.93%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $3.52 +0.01 (0.28%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Brokerage Reports
0 items in cart
Prime Medicine, Inc. [PRME]
Reports for Purchase
Showing records 1 - 9 ( 9 total )
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Steady Progress Across Diversified Pipeline; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
A PRIME Player on Gene Editing Court; Initiate With Buy and a $10 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: HE A
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
HEALTHCARE- ASGCT 2024 Abstract Roundup for Covered Companies
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Company: Prime Medicine, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM; Primed for Success
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
|